Sun Pharma shares are likely to be in focus on Monday following the company's announcement on Saturday that the U.S. District Court of New Jersey has issued a preliminary injunction blocking the launch of its new drug, Leqselvi, pending further legal developments or the expiration of the disputed patent.
Comments
Post a Comment